[Activated macrophages and cytotoxicity]. 1989

Y Yamamura

Cellular immune reaction plays an important role in tuberculous infection. When the host develops cellular immunity, a large number of activated macrophages (M phi) are accumulated in the tuberculous focus by the chemotactic effect of lymphokine, and these M phi lively phagocytize and suppress the multiplication of tubercle bacilli. On the other hand, many M phi are killed during the process of phagocytosis, releasing a large amount of lysosomal enzymes and cytotoxic substances (TNF etc.), possibly causing the tissue damage: caseous necrosis, softening and liquefaction followed by cavity formation. To clarify the process of necrosis in detail, production of TNF-alpha and IL-6 from human M phi was observed. Monocyte/M phi were separated from the peripheral blood of healthy persons, each group with positive or negative tuberculin reaction and tuberculous patients, using a commonly used method. The monocyte/M phi were stimulated in a culture with lipopolysaccharide (LPS) or muramyl dipeptide (MDP) and amount of TNF-alpha and IL-6 in the culture supernatants were estimated. TNF-alpha activity was determined by measuring the lysis of the target cell (mouse L929 cell), and IL-6 by measuring the 3H-thymidine incorporation into IL-6 dependent mouse plasma cell hybridoma, MH60-BSF2, in the presence of TNF-alpha or IL-6, respectively. The results showed that the monocyte/M phi from the tuberculin positive persons, with or without tuberculosis revealed a higher TNF-alpha production activity than those from tuberculin negative healthy cases using either MDP or LPS stimulation. The monocyte/M phi from tuberculous patients produced more TNF-alpha with MDP stimulation than with LPS.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Y Yamamura
December 1991, Kisaengch'unghak chapchi. The Korean journal of parasitology,
Y Yamamura
August 1977, Journal of the Reticuloendothelial Society,
Y Yamamura
March 1980, Journal of the Reticuloendothelial Society,
Copied contents to your clipboard!